Business news
Acne drug under the spotlight
Scientists at an Oxfordshire biotech firm have made a breakthrough in the treatment of acne.
Experts at Summit, based at Milton Park, near Didcot, have developed a new drug which has been found to cut the production of sebum, a fatty substance produced by glands in the skin. Excessive production of sebum is a primary cause of acne.
Clinical trials of the drug, known as SMT D002, revealed that sebum production was reduced by 90 per cent among 18 healthy volunteers.
It is estimated there are 54 million acne sufferers in the developed world with about eight million of those resistant to common treatments.
Bosses now plan to develop the drug in cream form and are looking for a partner to ensure it reaches the market.
10:28am Tuesday 15th April 2008
Print 
Email this
What are these links for?
If you liked this article and would like to share it with others on the web who might be searching for good content we've made it easy for you to do it.
At the bottom of all articles, you'll see links to six sites. These sites - commonly called 'social bookmark' or 'social news' sites - have large communities of web users who share and rate interesting, useful and fun things on the web.
Clicking the links will automatically add the address of the story you are reading to one of these sites, letting you share it with others. Each site will ask you to register to share stories. Registration is free and once a member, you can store, recommend and search for stories that interest you.
More on Digg
More on del.icio.us
More on Furl
More on reddit
More on NowPublic/
More on Yahoo!
